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Abstract Cancer cells usually exhibit aberrant cell signaling and metabolic reprogramming.
However, mechanisms of crosstalk between these processes remain elusive. Here, we show that in
an in vivo tumor model expressing oncogenic Drosophila Homeodomain-interacting protein kinase
(Hipk), tumor cells display elevated aerobic glycolysis. Mechanistically, elevated Hipk drives
transcriptional upregulation of Drosophila Myc (dMyc; MYC in vertebrates) likely through
convergence of multiple perturbed signaling cascades. dMyc induces robust expression of pfk2
(encoding 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase; PFKFB in vertebrates) among
other glycolytic genes. Pfk2 catalyzes the synthesis of fructose-2,6-bisphosphate, which acts as a
potent allosteric activator of Phosphofructokinase (Pfk) and thus stimulates glycolysis. Pfk2 and Pfk
in turn are required to sustain dMyc protein accumulation post-transcriptionally, establishing a
positive feedback loop. Disruption of the loop abrogates tumorous growth. Together, our study
demonstrates a reciprocal stimulation of Myc and aerobic glycolysis and identifies the Pfk2-Pfk
governed committed step of glycolysis as a metabolic vulnerability during tumorigenesis.
DOI: https://doi.org/10.7554/eLife.46315.001
Introduction
In the 1920s, Otto Warburg first discovered that cancer cells vigorously take up glucose and prefer-
entially produce lactate even in the presence of oxygen, a phenomenon now widely termed the War-
burg effect or aerobic glycolysis (Warburg et al., 1927). Despite his pioneering work, the Warburg
effect was largely disregarded for the subsequent decades (Liberti and Locasale, 2016;
Koppenol et al., 2011). After the discoveries of oncogenes and tumor suppressor genes, cancers
are generally considered as genetic diseases rather than metabolic ones (Wishart, 2015;
Seyfried et al., 2014). Not until the 1980s did the revisiting of the Warburg effect in connection
with oncogenes spark substantial research in cancer metabolism (Koppenol et al., 2011), laying the
foundation for 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography (PET) in
clinical cancer diagnosis (Vander Heiden et al., 2009; Ben-Haim and Ell, 2008), recognition of met-
abolic reprogramming as a hallmark of cancer (Hanahan and Weinberg, 2011; Ward and Thomp-
son, 2012) and development of anti-cancer agents targeting aerobic glycolysis (Ganapathy-
Kanniappan and Geschwind, 2013; Pelicano et al., 2006; Granchi and Minutolo, 2012).
How the Warburg effect arises and contributes to tumor progression have always been the center
in the field of cancer metabolism (Lu et al., 2015). Warburg hypothesized that mitochondrial
impairment is the cause of aerobic glycolysis and cancer (Warburg, 1956), which has sparked much
controversy among scientists (Senyilmaz and Teleman, 2015). Contrary to his idea, the current,
widely-accepted view is that oncogenic drivers such as RAS, MYC, hypoxia-inducible factors (HIFs)
and steroid receptor coactivators (SRCs) promote cancer cell proliferation and directly stimulate
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aerobic glycolysis through regulating transcriptional expression or catalytic activities of metabolic
enzymes (Koppenol et al., 2011). Several explanations for the Warburg effect have been put for-
ward, including rapid adenosine triphosphate (ATP) production and de novo biosynthesis of macro-
molecules (Liberti and Locasale, 2016). Recently, Warburg effect functions are being re-evaluated
as a growing body of evidence shows that metabolic rewiring in cancers impacts cell signaling and
epigenetics (Liberti and Locasale, 2016; Lu and Thompson, 2012).
Drosophila has proven to be a powerful genetic model organism for studying tumorigenesis in
vivo largely due to high conservation of genes and signaling cascades between human and flies and
reduced genetic redundancy (Gonzalez, 2013; Herranz and Cohen, 2017) (Supplementary file 1).
In a recent study, we showed that elevation of Drosophila Hipk causes an in vivo tumor model char-
acterized by tissue overgrowth, loss of epithelial integrity and invasion-like behaviors
(Blaquiere et al., 2018). The tumorigenic roles of Drosophila Hipk seem to be conserved in mam-
mals as the four members of the HIPK family (HIPK1-4) are also implicated in certain
cancers (Reviewed in Blaquiere and Verheyen, 2017). For example, HIPK1 is highly expressed in
breast cancer cell lines, colorectal cancer samples and oncogenically-transformed mouse embryo
fibroblasts (Kondo et al., 2003; Rey et al., 2013). Also, HIPK2 is elevated in certain cancers includ-
ing cervical cancers, pilocytic astrocytomas, colorectal cancer cells and in other proliferative diseases,
such as thyroid follicular hyperplasia (Al-Beiti and Lu, 2008; Cheng et al., 2012; Yu et al., 2009;
D’Orazi et al., 2006; Saul and Schmitz, 2013; Deshmukh et al., 2008; Lavra et al., 2011). To gain
a better understanding of cancer metabolism, we set out to use the fly Hipk tumor model to investi-
gate whether and how cellular metabolism is altered in tumor cells. We find that Hipk-induced
tumorous growth is accompanied by elevated aerobic glycolysis. Furthermore, we identify novel
eLife digest Cancer arises when cells in the body divide and grow excessively. These cells will
often also take up more glucose than normal cells and break it down into another chemical known
as lactate faster. This change to the chemical reactions happening within the cell, also called a
metabolic change, is required to help produce the extra DNA, proteins and fatty molecules that it
needs to grow.
Elevated levels of certain proteins can trigger the changes that lead to the growth of tumors.
MYC (called dMyc in fruit flies) is one of these proteins. It controls cell division and increases the
production of enzymes that break down glucose. Hipk is another protein that can induce tumor
growth in fruit flies, but how it does so was unknown.
Here, Wong et al. show that high levels of Hipk boost glucose metabolism and accumulation of
dMyc protein in fruit fly cells. They also describe the link between increased glucose metabolism and
uncontrolled cell division.
First, fruit fly cells were fed a fluorescent molecule similar to glucose that cannot be broken down
by the cells. This experiment established that glucose uptake increases in cells with too much Hipk.
These cells also break down glucose faster, confirming that they have increased glucose
metabolism.
Cells with high levels of Hipk also activate the genes that generate the enzymes involved in
glucose breakdown, and increase the activity of the gene coding for dMyc. Levels of the dMyc
protein are higher in these cells, which was shown by staining the cells with fluorescent molecules
that specifically bind the dMyc protein. It is this buildup of dMyc protein that activates the genes
coding for the enzymes responsible for glucose breakdown. PFK2 is one of these enzymes.
Finally, Wong et al. inhibited the production of the enzymes that are elevated in cells with high
Hipk. Stopping the production of PFK2 prevents both tumor growth and the accumulation of dMyc
protein. This shows that high levels of dMyc increase PFK2 levels, leading to further dMyc buildup,
and creating a loop that links the uncontrolled cell division caused by too much dMyc and the shift
to higher glucose metabolism.
These results highlight new potential targets for cancer therapy, showing that targeting glucose
metabolism may reduce, or even stop, tumor growth.
DOI: https://doi.org/10.7554/eLife.46315.002
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feedback mechanisms leading to prolonged dMyc expression and hence tumorigenesis. Our study
reveals potential metabolic vulnerabilities that could be exploited to suppress tumor growth.
Results
Hipk tumor cells exhibit elevated glucose uptake and consumption
Larval imaginal epithelia such as wing and eye-antennal imaginal discs, which give rise to wing and
eye structures in adult flies, respectively, are extensively used as tumor models to study human carci-
nomas (Herranz et al., 2016). To generate the Hipk tumor model, we used the Gal4-UAS system
(Brand and Perrimon, 1993) to induce overexpression of hipk in larval wing discs (full genotype:
dpp-Gal4>UAS-RFP + UAS-hipk, abbreviated as dpp>RFP + hipk) (Figure 1c–d). Fluorescent pro-
teins, for example red fluorescent proteins (RFP) or green fluorescent proteins (GFP), were co-
expressed to label the transgene-expressing cells. As previously reported (Blaquiere et al., 2018), in
contrast to control discs (dpp>RFP) (Figure 1a–b), tumorous growth and severe tissue distortions
were evident in hipk-expressing discs (dpp>RFP + hipk) (Figure 1c–d).
To ask if elevated Hipk alters cellular metabolism, we first used a fluorescently labeled glucose
analog, 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG) (Figure 1j). Like
D-glucose, 2-NBDG is transported into cells through glucose transporters and phosphorylated by
hexokinases (Yoshioka et al., 1996; O’Neil et al., 2005). However, due to the presence of the fluo-
rescent amino group at the C-2 position, 2-NBDG-6-phosphate cannot proceed further through gly-
colysis and is consequently trapped within the cells, rendering it a probe for monitoring glucose
uptake (O’Neil et al., 2005). 2-NBDG is often used in Drosophila to measure glucose uptake. For
example, overexpression of glut1 (encoding Glucose transporter 1) is sufficient to promote the accu-
mulation in 2-NBDG (Niccoli et al., 2016). Increased import of 2-NBDG is also found in dMyc-
expressing cells (de la Cova et al., 2014) and RasV12scrib /  tumor cells (Katheder et al., 2017),
indicating that such cells acquire enhanced glucose metabolism.
Similarly, we found that cells with elevated Hipk (RFP positive) in hipk-expressing wing discs
(dpp>RFP + hipk) exhibited statistically significant 2-NBDG accumulation when compared with the
neighboring wild-type cells (RFP negative) (Figure 1c–d and i) or cells (either RFP positive or nega-
tive) in control discs (dpp>RFP) (Figure 1a–b). A comparable phenomenon was seen in larval eye-
antennal discs (Figure 1—figure supplement 1a–b). Furthermore, we detected a mild upregulation
of glut1 (1.6-fold) in hipk-expressing discs by quantitative real-time PCR (qRT-PCR) (Figure 2a).
Knockdown of glut1 using RNA interference (RNAi) moderately reduced 2-NBDG incorporation in
Hipk tumor cells (Figure 1—figure supplement 1c–d). The knockdown efficiency of glut1-RNAi was
tested using a ubiquitous Gal4 driver, act5c-Gal4 (Figure 1—figure supplement 2a). Together,
these results suggest that elevated Hipk facilitates the import of glucose into cells at least in part
through augmenting Glut1 expression.
Next, we evaluated the intracellular glucose levels using a FRET (Fo¨rster resonance energy trans-
fer)-based glucose sensor, which is composed of a glucose-binding domain (GBD) fused with cyan
fluorescent protein (CFP) and yellow fluorescent protein (YFP) (Volkenhoff et al., 2018; Fehr et al.,
2003) (Figure 1l). The binding of glucose to GBD induces conformational changes, leading to
increased FRET efficiency (the ratio of FRET to CFP). Intriguingly, a lower FRET/CFP ratio indicative
of reduced glucose concentration was observed in hipk-expressing cells (Figure 1g–h and k) when
compared with control discs (Figure 1e–f and k). This implies that despite enhanced glucose uptake,
glucose is substantially utilized in the rapidly proliferating Hipk tumor cells.
Elevated Hipk induces robust expression of a subset of glycolytic genes
Glycolysis is a catabolic process that breaks down glucose into pyruvate via multiple enzymatic
steps. To ask if glycolysis is upregulated, we examined the expression profile of glycolytic genes by
qRT-PCR and changes greater than 1.5-fold were considered significant. We isolated RNA from
whole wing discs expressing either GFP (control) or hipk under the dpp-Gal4 driver control. qRT-
PCR analyses revealed that genes encoding Hexokinases (Hex-A and Hex-C, 2.2-fold and 4.3-fold
respectively), Phosphoglucose isomerase (Pgi, 2.4-fold), Phosphofructokinase 2 (Pfk2, also known as
Pfrx, 2.7-fold) and Lactate dehydrogenase (Ldh, also known as Impl3, 3.4-fold) are significantly
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Figure 1. Hipk tumor cells exhibit elevated glucose uptake and reduced intracellular glucose levels. (a–d)
Incorporation of 2-NBDG (green) in control (dpp>RFP) (a, b) and hipk-expressing (dpp>RFP + hipk) wing discs (c,
d). Insets (dashed line) in (a and c) are magnified in (b and d), respectively. RFP (red) marks the transgene-
expressing cells. F-actin (gray) staining shows the overall tissue morphology. (e–h) Intracellular glucose FRET
efficiency (FRET/CFP) (colored using Fire Lookup Table) in control (dpp>Glucose Sensor) (e–f) and hipk-expressing
(dpp>Glucose Sensor+hipk) wing discs (g–h). Individual CFP and FRET channels are shown in cyan and yellow,
respectively. Insets (dashed line) in (e and g) are magnified in (f and h), respectively. Insets (solid line) at the upper
right corners in (e–e’’) and (g–g’’) show the corresponding signals at single pixel level. (i) Quantification of mean 2-
NBDG intensity in hipk-expressing cells (RFP positive) and the neighboring wild-type cells (RFP negative) in hipk-
expressing wing discs (dpp >RFP + hipk) (n = 12 wing discs). (j) Chemical structures of D-glucose (top) and 2-
NBDG (bottom). (k) Quantification of glucose FRET efficiency in control (dpp>Glucose Sensor) and hipk-
expressing (dpp >Glucose Sensor + hipk) wing discs (n = 11 wing discs per genotype). (l) Schematic diagram of
the FRET-based glucose sensor. Glucose binding induces conformational changes of glucose-binding domain
(GBD) such that FRET occurs and YFP emission increases. Scale bars, 50 mm. Exact p values are shown and
calculated using unpaired two-tailed t-test.
DOI: https://doi.org/10.7554/eLife.46315.003
The following source data and figure supplements are available for figure 1:
Source data 1. Analyses of glucose metabolism in Hipk tumor cells and evaluation of RNAi tools.
DOI: https://doi.org/10.7554/eLife.46315.006
Figure supplement 1. Elevated Hipk stimulates 2-NBDG uptake in a Glut1-dependent manner.
DOI: https://doi.org/10.7554/eLife.46315.004
Figure 1 continued on next page
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upregulated in hipk-expressing discs (Figure 2a–b). Expression of other glycolytic genes, on the
other hand, remained relatively unchanged.
As the Dpp domain comprises 10–20% of the wing disc, the glycolytic gene upregulation within
hipk-expressing cells is likely understated. In light of such a limitation, we used a GFP-based
enhancer trap to monitor Ldh transcription in vivo (Ldh-GFP) (Quin˜ones-Coello et al., 2007). In con-
trol wing discs, little Ldh-GFP was detected (Figure 2c), indicating that Ldh is minimally expressed
under physiological conditions as previously described (Wang et al., 2016). On the contrary, we
observed robust Ldh-GFP expression in hipk-expressing wing discs (Figure 2d), confirming that ele-
vated Hipk induces Ldh expression.
Hexokinases phosphorylate glucose to form glucose-6-phosphate (G6P), which is the first essen-
tially irreversible step in glycolysis (Figure 2b). Pgi catalyzes the reversible conversion of G6P and
fructose-6-phosphate. Pfk2 is a bifunctional enzyme that synthesizes fructose-2,6-bisphosphate
Figure 1 continued
Figure supplement 2. Knockdown efficiencies of the RNAi lines targeting glycolytic genes.
DOI: https://doi.org/10.7554/eLife.46315.005
Figure 2. Elevated Hipk induces robust expression of a subset of glycolytic genes. (a, b) qRT-PCR analysis of
glycolytic gene expression in hipk-expressing discs (dpp>hipk) relative to control discs (dpp>GFP) (a). Data are
mean ± sem. n = 3 independent experiments with samples pooled from 10 to 20 wing discs per genotype.
Schematic diagram of glycolysis (b). Fold changes are shown in brackets. Glycolytic enzymes with more than 1.5-
fold transcriptional upregulation in hipk-expressing discs are marked in red. Bi- and uni-directional arrows indicate
the reversible and essentially irreversible steps in glycolysis, respectively. Dashed arrow (blue) shows the positive
allosteric regulation of Pfk by fructose-2,6-BP. Full names of the glycolytic genes are provided in
Supplementary file 1. Exact p values are shown and calculated using unpaired two-tailed t-test. (c–d) Expression
of Ldh-GFP (green), an enhancer trap to monitor Ldh expression, in control (genotype: Ldh-GFP/+) (c) and hipk-
expressing wing discs (genotype: Ldh-GFP/dpp>hipk) (d). DAPI staining for DNA (blue) reveals tissue morphology.
White arrowhead in d’’ indicates marked induction of Ldh expression. Scale bars, 50 mm.
DOI: https://doi.org/10.7554/eLife.46315.007
The following source data is available for figure 2:
Source data 1. Expression profile of glycolytic genes inhipk-expressing discs.
DOI: https://doi.org/10.7554/eLife.46315.008
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(F2,6-BP). F2,6-BP is a potent allosteric activator of Pfk, which governs the committed, second irre-
versible step in glycolysis. Ldh, similar to LDHA in vertebrates (Rechsteiner, 1970), favors the reduc-
tion of pyruvate to lactate, regenerating nicotinamide adenine dinucleotide (NAD+) such that
glycolysis continues unabated (Valvona et al., 2016). The robust upregulation of these glycolytic
enzymes in hipk-expressing discs is in agreement with previous data implying that glucose consump-
tion is stimulated. Taken together, the results support the hypothesis that Hipk tumor cells exhibited
elevated glycolytic activities, resembling the Warburg effect seen in cancers.
Elevated Hipk drives dMyc upregulation in a region-specific manner
To elucidate the underlying mechanisms for the metabolic alterations in the Hipk tumors, we exam-
ined gene expression of dMyc and Sima (HIF1-a in vertebrates) since these two transcription factors
are well-known inducers of glycolysis in cancer cells (Miller et al., 2012a; Marı´n-Herna´ndez et al.,
2009). qRT-PCR analyses showed that dMyc was upregulated in hipk-expressing discs whereas sima
expression remained unchanged (Figure 3a).
Larval wing discs are mainly composed of three regions known as the notum, hinge and pouch,
corresponding to the adult structures they give rise to (Figure 3b). Using a dMyc-lacZ enhancer trap
(encoding b-galactosidase (b-gal)) to monitor the transcriptional control of dMyc in vivo, we
observed that dMyc was expressed at high levels in the pouch region of control discs (Figure 3c). In
the hinge and notum areas of control discs, dMyc was minimally and weakly expressed, respectively
(Figure 3c). In hipk-expressing discs, we found intense b-galactosidase staining, confirming that
Hipk cell-autonomously drives transcriptional upregulation of dMyc. Interestingly, the increase in the
b-gal signal intensity appeared to be the largest in the wing hinge (Figure 3d, arrowhead) where the
Figure 3. Elevated Hipk drives dMyc upregulation in a region-specific manner. (a) qRT-PCR analysis of dMyc and sima expression in hipk-expressing
discs (dpp>hipk) relative to control discs (dpp>GFP). Data are mean ± sem. n = 3 independent experiments with samples pooled from 10 to 20 wing
discs per genotype. Exact p values are shown and calculated using unpaired two-tailed t-test. (b) Schematic diagram of a larval wing imaginal disc, with
notum, hinge and pouch in light gray, dark gray and white, respectively. (c–d) b-galactosidase staining (red) in control (dpp>GFP) (c) and hipk-
expressing (dpp>GFP + hipk) (d) wing discs harboring a lacZ reporter to monitor the transcriptional induction of dMyc (dMyc-lacZ). White arrowhead in
(d’) indicates robust upregulation of dMyc in the wing hinge. (e–f) dMyc staining (gray) in control (dpp>GFP) (e) and hipk-expressing (dpp>GFP + hipk)
(f) wing discs. White arrowhead in (f’) indicates dMyc accumulation in the wing hinge. GFP (green) marks the transgene-expressing cells. Scale bars, 50
mm.
DOI: https://doi.org/10.7554/eLife.46315.009
The following source data is available for figure 3:
Source data 1. Expression levels ofdMycandsimainhipk-expressing discs.
DOI: https://doi.org/10.7554/eLife.46315.010
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tumor cells proliferated most rapidly, while the intensity faded when moving away from the hinge
region (Figure 3d).
Immunofluorescent staining using antibodies against dMyc confirmed the accumulation of dMyc
proteins in Hipk tumor cells especially in the wing hinge (Figure 3e–f), which positively correlates
with the marked increase in dMyc mRNA levels in the same region (Figure 3d). dMyc proteins
appeared to not accumulate in hipk-expressing cells in the wing pouch (Figure 3f), possibly due to
weak induction in dMyc transcription (Figure 3d).
The variability in Hipk-induced dMyc accumulation suggests a potential region-specificity in dMyc
upregulation. To assess this, we generated random flip-out clones of hipk-expressing cells. The
clones were marked by RFP. We observed that hipk-expressing clones located in the dorsal hinge
(Figure 4c, arrowhead, Figure 4—figure supplement 1a), the lateral hinge (Figure 4—figure sup-
plement 1b) as well as the epithelium on the peripodial side exhibited marked dMyc accumulation
(Figure 4—figure supplement 1c). On the contrary, when hipk-expressing clones were located in
the wing pouch, dMyc levels appeared unchanged (Figure 4—figure supplement 1d). Altogether,
our data imply that elevated Hipk drives dMyc upregulation in a region-specific manner.
Elevated Hipk modulates dMyc expression likely through convergence
of multiple perturbed signaling cascades
We further investigated the molecular mechanisms underlying the upregulation of dMyc in Hipk
tumor cells. Earlier studies have demonstrated that Hipk is a versatile regulator of numerous signal-
ing pathways. For example, Hipk stimulates the transcriptional activity of Yorkie (Yki, a Drosophila
Figure 4. Elevated Hipk and perturbations in cell signaling cascades induce dMyc accumulation in the wing hinge region. (a) dMyc staining (gray) in a
control wing disc. (b) Schematic diagram of a larval wing imaginal disc. The hinge region can be divided into dorsal, lateral and ventral compartments.
(c–g) dMyc staining (gray) in flip-out clones expressing hipk (c), yki-S168A (d), Arm-S10 (e), Ci (f) or N-act (g) under the control of actin-Gal4. RFP (red)
marks the transgene-expressing clones. DAPI staining for DNA (blue) reveals tissue morphology. (c’, c’’-g’, g’’) are magnified images of the insets
(dashed lines) in (c-g). (c) White arrowhead indicates dMyc accumulation in a hipk-expressing clone. (d) White arrowheads indicate yki-S168A-expressing
clones with dMyc accumulation. (e) White arrowheads indicate ectopic dMyc expression at the boundary of the Arm-S10-expressing clone and the
neighboring wild-type cells. (f) White arrowheads indicate dMyc upregulation in Ci-expressing clones. (g) White arrowheads indicate dMyc
accumulation in N-act-expressing clones and the adjacent wild-type cells. Scale bars, 50 mm.
DOI: https://doi.org/10.7554/eLife.46315.011
The following figure supplement is available for figure 4:
Figure supplement 1. Effects on dMyc expression by elevated Hipk or perturbations in cell signaling.
DOI: https://doi.org/10.7554/eLife.46315.012
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orthologue of YAP/TAZ), the effector of the Hippo tumor suppressor pathway (Chen and Verheyen,
2012; Poon et al., 2012). Hipk also functions as a positive regulator of both Wnt/Wingless (Wg) and
Hedgehog signaling by stabilizing Armadillo (b-catenin in vertebrates) and Cubitus interruptus (Ci;
Gli in vertebrates), respectively (Lee et al., 2009a; Swarup and Verheyen, 2011). In addition, Hipk
has been found to antagonize Groucho, a global co-repressor, to promote Notch signal transduction
(Lee et al., 2009b). If Hipk-induced dMyc upregulation is through deregulation of multiple signaling
pathways, we would expect to see dMyc accumulation when the signaling pathways are perturbed.
We first focused on the dorsal hinge area since ectopic dMyc expression and tumor growth are most
striking in such region in hipk-expressing discs.
Flip-out clones expressing a constitutively active form of Yki (Yki-S168A) to inactivate the Hippo
pathway were usually round and most of them in the dorsal hinge displayed dMyc upregulation
(Figure 4d, arrowheads). Wing discs with flip-out clones expressing an active form of Arm (Arm-S10)
featured an expansion in the hinge area and some dMyc accumulated at the interface between the
clone and the neighboring wild-type cells (Figure 4e, arrowheads) but not at the center of the clone.
Flip-out clones expressing Ci to activate Hedgehog signaling in the hinge region were round or
irregular in shape and exhibited elevated levels of dMyc (Figure 4f, arrowheads). Consistent with
previous findings (Djiane et al., 2013), expression of activated Notch appeared to induce dMyc
accumulation in both cell and non-cell autonomous fashions in the hinge area likely involving a sig-
naling relay (Figure 4g). Therefore, individual perturbation of signaling pathways that have been
previously shown to be regulated by Hipk was sufficient to trigger ectopic dMyc expression in the
hinge region.
In the wing pouch region, activation of Yki failed to cause any dMyc upregulation (Figure 4—fig-
ure supplement 1e). This is in contrast to previous findings that overexpression of Yki increased
dMyc protein levels in both hinge and pouch regions (Ziosi et al., 2010). Such discrepancy could be
due to the different expression levels of the UAS-Yki constructs. Flip-out clones expressing Arm-S10
or activated Notch displayed reduced dMyc expression (Figure 4—figure supplement 1f and h),
which is consistent with earlier studies showing that Wg and Notch signaling negatively regulate
dMyc expression in the pouch region (Duman-Scheel et al., 2004; Herranz et al., 2008). Clones
with Ci overexpression were few and tiny in the wing pouch and the dMyc levels in the clones
seemed comparable to those in the neighboring wild-type cells (Figure 4—figure supplement 1g).
Our data suggest that the region specificity in dMyc upregulation applies to not only Hipk tumor
cells, but also cells with other tumorigenic stimuli.
In summary, our data show that in the wing hinge region where Hipk tumor growth is most promi-
nent, dMyc protein markedly accumulates. Individual perturbations in signaling pathways that have
been shown to be regulated by Hipk also result in ectopic dMyc expression in the same region.
Hence, it is likely that in the rapidly proliferating Hipk tumor cells, aberrant signals propagate and
converge at the transcriptional control of dMyc. In other words, the modulation of dMyc levels by
Hipk seems to be a cumulative effect of alterations in multiple signaling outputs.
Hipk-induced dMyc governs aerobic glycolysis and tumor growth
In addition to growth control, dMyc/MYC plays a conserved role in upregulating glycolysis in verte-
brates and Drosophila during normal development and in cancers (de la Cova et al., 2014; Gal-
lant, 2013). As expected and previously reported (de la Cova et al., 2014), overexpression of dMyc
caused marked 2-NBDG uptake (Figure 5a and d) and promoted glycolytic gene expression
(Figure 5e). More importantly, knockdown of dMyc by RNAi in hipk-expressing discs reversed the 2-
NBDG accumulation (Figure 5b–d) and moderately suppressed glycolytic gene upregulation
(Figure 5e), suggesting that dMyc is essential for the enhanced glycolysis in Hipk tumor cells. Addi-
tionally, knockdown of dMyc significantly suppressed the tumorous growth and tissue distortions in
hipk-expressing discs, as seen by the decrease in GFP positive cells (Figure 5f–g). Using an indepen-
dent RNAi construct targeting dMyc (dMyc-RNAi #2), we observed a similar effect upon silencing of
dMyc (Figure 5h). dMyc immunofluorescent staining showed the efficient knockdown when dMyc-
RNAi constructs were expressed (Figure 5g–i). Wing discs with dMyc knockdown alone appeared
wild-type (Figure 5i). Altogether, our results imply that dMyc-induced glycolysis may be a key driver
for Hipk tumor growth. Intriguingly, overexpression of dMyc alone (Figure 5a), despite the
enhanced glycolysis, failed to reproduce the tumorous phenotypes observed in hipk-expressing discs
Wong et al. eLife 2019;8:e46315. DOI: https://doi.org/10.7554/eLife.46315 8 of 19
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Figure 5. dMyc mediates the Hipk-induced glycolysis and tumor growth. (a–c) Incorporation of 2-NBDG (green) in dMyc-expressing wing disc
(dpp>dMyc) (a), hipk-expressing wing disc (dpp>RFP + hipk) (b), and hipk-expressing wing disc with dMyc knockdown (dpp>RFP + hipk + dMyc-RNAi)
(c). Insets (dashed line) in (a, b and c) are magnified in (a’–a’’), (b’–b’’) and (c’–c’’), respectively. dMyc staining (gray) in (a) marks the dMyc-
overexpressing cells. RFP (red) in (b and c) marks the transgene-expressing cells. (d) Quantification of mean 2-NBDG intensity in dMyc-expressing cells
and the neighboring wild-type cells in dMyc-expressing wing discs (dpp>dMyc) (left), in hipk-expressing cells (RFP positive) and the neighboring wild-
type cells (RFP negative) in hipk-expressing discs (dpp>RFP + hipk) (middle) and, in hipk, dMyc-RNAi co-expressing cells (RFP positive) and the
neighboring wild-type cells (RFP negative) in hipk-expressing discs with dMyc knockdown (dpp>RFP + hipk + dMyc-RNAi) (right). n = 6 discs per
genotype. (e) qRT-PCR analysis of expression of a set of glycolytic genes in hipk-expressing wing discs (dpp>hipk), hipk-expressing discs with dMyc
knockdown (dpp>hipk + dMyc-RNAi), and dMyc-expressing discs relative to control discs (dpp>GFP). Data are mean ± sem. n = 3 independent
experiments with samples pooled from 10 to 20 wing discs per genotype. (f–i) dMyc staining (gray in f’’), (g’’, h’’ and i’’) in hipk-expressing disc
(dpp>GFP + hipk) (f), hipk and dMyc-RNAi co-expressing disc (dpp>GFP + hipk + dMyc-RNAi) (g), hipk and dMyc-RNAi #2 co-expressing disc
(dpp>GFP + hipk + dMyc-RNAi #2) (h) and dMyc knockdown disc (dpp>GFP + dMyc-RNAi) (i). GFP (green) marks the transgene-expressing cells. DAPI
staining for DNA (blue) reveals tissue morphology. Scale bars, 50 mm. Exact p values are shown and calculated using unpaired two-tailed t-test.
Figure 5 continued on next page
Wong et al. eLife 2019;8:e46315. DOI: https://doi.org/10.7554/eLife.46315 9 of 19
Research article Cancer Biology Cell Biology
(Figure 5f). Thus, while upregulation of dMyc is indispensable for Hipk-induced glycolysis and tumor
growth, additional mechanisms are involved in the Hipk tumors to trigger the tumorigenic process.
Aerobic glycolysis (the Warburg effect) is essential to tumor growth
through sustaining ectopic dMyc expression
Earlier studies have shown that flies incompetent at glycolysis displayed reduced viability as deletion
or ubiquitous knockdown of the glycolytic genes pfk, ald, pgk, pglym78, eno or pyk resulted in
lethality (Volkenhoff et al., 2015; Gerber et al., 2006; Miller et al., 2012b; Tennessen et al.,
2011). Likewise, we observed that flies ubiquitously depleted of pgk (act5c>pgk-RNAi) failed to
reach the larval stage. Flies lacking pfk (act5c>pfk-RNAi) or pyk (act5c>pyk-RNAi) reached the larval
stage but could not pupariate. Flies with pfk2 knockdown (act5c>pfk2-RNAi) died at the early pupal
stage but did not differentiate further to become late pupae. Most flies lacking glut1 (act5c>glut1-
RNAi) or pgi (act5c>pgi-RNAi) succeeded in emerging as adults. The timing of lethality following
knockdown targeting glycolytic genes could presumably be influenced by maternal contribution,
knockdown efficiency or the importance of the glycolytic step which the particular enzyme controls.
To confirm the regulatory roles of Pfk and Pfk2 in glycolytic flux, we measured the relative pyruvate
content in the knockdown larvae. Consistent with previous work (Li et al., 2018), knockdown of pfk
significantly decreased pyruvate levels (Figure 6—figure supplement 1). Similarly, knockdown of
pfk2 induced an approximately 60% drop in the pyruvate content (Figure 6—figure supplement 1).
The knockdown efficiencies of all RNAi constructs used in this study to silence glycolytic genes were
evaluated by qRT-PCR analyses (Figure 1—figure supplement 2).
To examine the roles of glycolytic activation in Hipk tumor cells, we used RNAi to deplete key gly-
colytic genes. Knockdown of hex-A or hex-C had negligible effects on Hipk tumor growth; as did
hex-A and hex-C double knockdown (Figure 6—figure supplement 2). Similarly, knockdown of
glut1 or pgi failed to block Hipk-induced tumorigenesis (Figure 6—figure supplement 3a–b).
Knockdown of pfk2, on the contrary, markedly prevented tumor growth and restored tissue architec-
ture in hipk-expressing discs (Figure 6b), suggesting that the committed step of glycolysis deter-
mines Hipk tumorigenesis. Indeed, the effect of pfk knockdown was comparable to that of pfk2
knockdown (Figure 6c), even though we did not detect significant pfk upregulation (<1.5 fold) in
hipk-expressing discs (Figure 2a). Knockdown of pgk, pyk or Ldh appeared to slightly restrict Hipk
tumor growth but the tissue morphology remained distorted (Figure 6d, Figure 6—figure supple-
ment 3c–d).
We also examined dMyc expression in Hipk tumor cells when glycolysis was inhibited. Intriguingly,
dMyc accumulation was largely abolished in hipk-expressing discs when pfk2 or pfk was knocked
down (Figure 6a–c). In the absence of hipk overexpression, neither knockdown of pfk nor pfk2
affected the normal dMyc expression pattern nor led to defects in tissue growth (Figure 6—figure
supplement 4). Knockdown of glut1, pgi, pgk, pyk or Ldh in Hipk tumor cells did not rescue dMyc
upregulation (Figure 6d, Figure 6—figure supplement 3). Together, our results suggest that dMyc
accumulation and the associated Hipk tumor growth are most sensitive to the committed step of gly-
colysis governed by Pfk2-Pfk.
Using the dMyc-lacZ reporter, we found that dMyc transcriptional activation remained robust
when pfk2 or pfk was depleted in Hipk tumor cells even though the tumor growth was reduced and
dMyc protein levels were reduced (Figure 6e–g). Thus, our data indicate that Pfk2 and Pfk are
required to sustain ectopic dMyc expression specifically in Hipk tumor cells through post-transcrip-
tional regulation.
The control of Hipk tumor growth by Pfk2 or Pfk seemed not to be a consequence of altered
Hipk protein stability or functions because of the following reasons. First, we did not detect a notice-
able change in Hipk protein levels in discs depleted of pfk2 or pfk when compared with discs
Figure 5 continued
DOI: https://doi.org/10.7554/eLife.46315.013
The following source data is available for figure 5:
Source data 1. Analyses of glucose metabolism inhipk-expressing discs upondMycknockdown.
DOI: https://doi.org/10.7554/eLife.46315.014
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expressing hipk alone (Figure 6e–g), indicating that blocking glycolysis does not trigger Hipk pro-
tein degradation. Second, the robust stimulation of the dMyc-lacZ reporter in hipk-expressing discs
with pfk2 or pfk knockdown suggests that Hipk activities remain intact. Indeed, when we examined
other signaling targets downstream of Hipk as readouts for Hipk activity, we found that Hipk-medi-
ated stabilization of Armadillo (Wnt/Wg signaling), and induction of Cyclin E or expanded-lacZ
Figure 6. Pfk2 and Pfk sustain Hipk tumor growth through post-transcriptional regulation of dMyc. (a–d) dMyc
staining (gray in a’’, b’’, c’’ and d’’) in hipk-expressing wing disc (dpp>GFP + hipk) (a), hipk and pfk2-RNAi co-
expressing disc (dpp>GFP + hipk + pfk2-RNAi) (b), hipk and pfk-RNAi co-expressing disc (dpp>GFP + hipk + pfk-
RNAi) (c) and hipk and Ldh-RNAi co-expressing disc (dpp>GFP + hipk + Ldh-RNAi) (d). GFP (green) marks the
transgene-expressing cells. DAPI staining for DNA (blue) reveals tissue morphology. (e–g) Hipk staining (magenta
in e, f and g) and b-galactosidase staining (red in e’, f’ and g’) in hipk-expressing disc (dpp>hipk) (e), hipk and
pfk2-RNAi co-expressing disc (dpp>hipk + pfk2-RNAi) (f), hipk and pfk-RNAi co-expressing disc (dpp>hipk + pfk-
RNAi) (g). All wing discs harbor a lacZ reporter to monitor the transcriptional induction of dMyc (dMyc-lacZ). Scale
bars, 50 mm.
DOI: https://doi.org/10.7554/eLife.46315.015
The following source data and figure supplements are available for figure 6:
Source data 1. Data for pyruvate measurements.
DOI: https://doi.org/10.7554/eLife.46315.021
Figure supplement 1. Larvae depleted of pfk2 or pfk display decreases in the pyruvate levels.
DOI: https://doi.org/10.7554/eLife.46315.016
Figure supplement 2. Hexokinases are not required for Hipk tumor growth.
DOI: https://doi.org/10.7554/eLife.46315.017
Figure supplement 3. Non-targeted inhibition of glycolysis is not sufficient to prevent Hipk tumor growth or
ectopic dMyc accumulation.
DOI: https://doi.org/10.7554/eLife.46315.018
Figure supplement 4. Pfk2 and Pfk do not affect dMyc expression in the absence of hipk overexpression.
DOI: https://doi.org/10.7554/eLife.46315.019
Figure supplement 5. Knockdown of pfk2 or pfk does not affect Hipk functions.
DOI: https://doi.org/10.7554/eLife.46315.020
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(Hippo signaling) remained unaffected by knockdown of pfk2 or pfk in a Hipk overexpression back-
ground, indicating Hipk is still functional (Figure 6—figure supplement 5).
Altogether, our data suggest that while dMyc upregulation promotes glycolytic activities, the
upregulation of Pfk2, along with subsequent F2,6-BP biosynthesis and Pfk activation, is required to
foster the accumulation of dMyc proteins. In other words, a positive feedback loop between dMyc
and aerobic glycolysis is formed, coordinating growth signals with metabolic states to reinforce
tumor progression.
Discussion
dMyc-driven aerobic glycolysis in a hipk tumor model
Multiple approaches and tools have been developed to measure glycolysis including measurement
of the extracellular acidification rate (ECAR), fluorescent probes, biosensors, fluorescent/colorimetric
assays and mass spectrometry (Bittner et al., 2010; TeSlaa and Teitell, 2014; Tennessen et al.,
2014). In the Hipk tumor model, the tumor cells are surrounded by wild-type cells. Our study primar-
ily used fluorescence imaging such that we could examine changes in metabolite levels, gene and
protein expression between tumor cells and the adjacent wild-type cells. Our work delineates the
causes and significance of metabolic changes in tumor cells.
Drosophila tumor models frequently acquire metabolic changes, especially the Warburg effect.
For instance, epidermal growth factor receptor (EGFR)-driven tumors, tumors with activated plate-
let-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) receptor (Pvr) and
tumors with polarity loss (such as scrib or dlg mutant tumors) feature robust upregulation of Ldh
among other glycolytic genes (Wang et al., 2016; Eichenlaub et al., 2018; Bunker et al., 2015).
Depletion of Ldh was shown to reduce growth of EGFR-driven tumors but not tumors with polarity
loss (Eichenlaub et al., 2018; Bunker et al., 2015). In RasV12scrib /  tumors, elevated glucose
uptake was evident, but its significance was not evaluated (Katheder et al., 2017). Similar to the
previously described models, Hipk tumor cells exhibited elevated glucose metabolism (Figures 1–
2). Metabolic reprogramming was driven by dMyc upregulation (Figures 3–5). Although the tran-
script levels of another glycolytic inducer sima remained unchanged (Figure 3a), we could not elimi-
nate the possibility that Sima protein levels are altered in the tumor cells. Thus, whether Sima is
involved in the tumor growth warrants further studies. Genetical inhibition of Pfk or Pfk2 was suffi-
cient to block Hipk-induced tumorigenesis whereas depletion of Pgk, Pyk or Ldh at most slightly
reduced tumor growth (Figure 6; Figure 6—figure supplement 3). Therefore, our data suggest that
targeted but not generic inhibition of glycolysis is required to abrogate tumor growth.
A feedback loop between dMyc and aerobic glycolysis as a metabolic
vulnerability in tumor cells
Although MYC functions in cancer metabolism are widely recognized, MYC is generally considered
‘undruggable’ largely due to its nuclear localization, lack of an enzymatic ‘active site’, and indispens-
able roles during normal development (Soucek and Evan, 2010). Hence, limited therapeutic strate-
gies have been developed, and identification of the ‘druggable’ regulatory proteins of MYC
becomes critical.
Our study reveals two modes of dysregulation of endogenous dMyc specifically during Hipk-
induced tumorigenesis. The first mode is transcriptional stimulation of dMyc likely as a consequence
of convergence of multiple signaling outputs (Figures 3–4). In our previous study, we found that
genetically targeting individual signaling cascades failed to restrain Hipk tumor growth
(Blaquiere et al., 2018). This is likely due to the redundancy of signaling cascades in inducing dMyc
upregulation. It is also interesting to note that dMyc upregulation and the associated tumor growth
are most striking in the wing hinge (Figures 3–4). The pouch region, however, seems more refrac-
tory to such alterations. We also observed the lowest intracellular glucose levels (Figure 1g–h) and
robust Ldh upregulation (Figure 2d) in the hinge area. dMyc-dependent glucose uptake (Figure 5b–
c), on the other hand, was enhanced in both hinge and pouch regions even though dMyc protein
buildup is undetectable in the wing pouch, suggesting that glucose uptake is particularly sensitive to
changes in dMyc levels. Our data therefore imply that the Warburg effect and the tumor growth
phenotype may be linked to the dMyc levels being induced. The region-specific susceptibility to
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tumorigenic stimuli has been previously described and the hinge region was coined a ‘tumor hot-
spot’ because of its unique epithelial cell architectures and high endogenous JAK/STAT signaling
(Tamori et al., 2016). It is possible that such features in the hinge region also contribute to the sen-
sitivity of dMyc upregulation by elevated Hipk and other signaling pathways. Further studies are
required to verify this proposition.
The second mode of dMyc regulation is the metabolic control of dMyc protein levels by aerobic
glycolysis. Specifically, we found that the rate-limiting enzymes Pfk2 and Pfk are required to perpetu-
ate dMyc buildup in tumor cells in a post-transcriptional manner (Figure 6). Similar to the effects on
tumor growth, while pfk2/pfk knockdown prevented dMyc accumulation, knockdown of other glyco-
lytic enzymes had little effect on sustaining dMyc accumulation. Such a disparity could possibly be
explained by the potency of the glycolytic enzymes in controlling glycolytic flux. While Pfk2 and Pfk
govern the rate-limiting, committed step of glycolysis, RNAi targeting other glycolytic genes may fail
to render the corresponding steps rate-limiting, especially in tumors with elevated aerobic glycolysis.
In other words, knockdown of other glycolytic enzymes may not reach the threshold that would
restrict glycolytic flux as potently as pfk2/pfk knockdown. Given that Pfk2 is mis-expressed in tumor
cells but not in normal cells (Figure 2a) and that dMyc accumulation is most sensitive to the Pfk2-Pfk
mediated committed step of glycolysis specifically in tumor cells (Figure 6), targeting Pfk2 may be a
favorable, selective metabolic strategy in the treatment of cancers, especially those displaying
ectopic MYC expression.
Potential pro-tumorigenic roles of the pfk and Pfk2 in addition to their
core biochemical role in glycolysis
The human homologs of fly Pfk and Pfk2 are PFK and PFK-2/FBPase (PFKFB), respectively. The func-
tions of mammalian PFK and PFKFB in controlling glycolytic flux are well-defined. The allosteric regu-
lation of PFK by F2,6-BP seems to be conserved among mammals and insects as F2,6-BP is able to
activate insect Pfk, likely due to the conserved amino acid residues for F2,6-BP binding
(Nunes et al., 2016). This suggests that Pfk2 can induce Pfk activation and hence glycolytic flux
through biosynthesizing F2,6-BP. A previous report shows that flies lacking pfk2 exhibited levels of
circulating glucose and reduced sugar tolerance, providing a functional link between Pfk2 and glu-
cose metabolism (Havula et al., 2013). We provide evidence that both pfk2 and pfk knockdown lar-
vae exhibited significant decreases in pyruvate contents, confirming a conserved role of Pfk2 in
regulating glycolytic flux.
Recently, the roles of PFK and PFKFB in the regulation of transcription factors or cofactors have
drawn considerable attention. For example, vertebrate PFK was shown to physically interact with
TEAD factors to stimulate YAP/TAZ activity, thus promoting proliferation and malignancy in cancer
cells (Enzo et al., 2015). PFKFB4 (an isoform of PFK2) phosphorylates and activates oncogenic SRC-
3 to promote breast cancers through stimulating purine synthesis (Dasgupta et al., 2018). These
studies point to the fact that PFK and PFKFB functions are not restricted to metabolic regulation.
Thus, it is tempting to speculate that Pfk2/Pfk may sustain ectopic dMyc through a direct interaction
with or even phosphorylation of dMyc. That being said, as knockdown of Pfk2 or Pfk had no effects
on dMyc protein levels under normal conditions (Figure 6—figure supplement 4), we tend to
believe that a tumorigenic environment with active aerobic glycolysis is necessary for the metabolic
control of dMyc in particular through the committed step governed by Pfk2/Pfk. In summary, we
and others show that glycolytic enzymes Pfk and Pfk2, likely through their core biochemical role in
stimulating glycolytic flux, glycolysis-independent actions or both, act as key players in coupling met-
abolic demands with growth signals to achieve cancer progression.
Materials and methods
Drosophila genetics
Drosophila melanogaster flies were raised on standard cornmeal-molasses food. Stocks were kept at
25˚C and crosses at 29˚C unless otherwise indicated. Three Gal4 fly lines, (1) dpp-Gal4/TM6B, (2) hh-
Gal4/TM6B and (3) act5c-Gal4/TM6B (BL #3954) were used to induce transgene expression. To gen-
erate heat-shock inducible actin flip-out clones, (4) yw,hsFlp[122];;act>CD2>Gal4, UAS-RFP/TM6B
was used. To mark the transgene-expressing cells, (5) UAS-GFP (BL #5431) and (6) UAS-RFP (BL
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#7118) were used. To generate the Hipk tumor model, (7) UAS-HA-hipk-3M (abbreviated as UAS-
hipk) (Swarup and Verheyen, 2011) and (8) dpp-Gal4, UAS-hipk/TM6B were used. RNAi fly strains
used include (9) UAS-dMyc-RNAi (BL #25783), (10) UAS-dMyc-RNAi #2 (BL #25784), (11) UAS-glut1-
RNAi (BL #40904), (12) UAS-hex-A-RNAi (BL #35155), (13) UAS-hex-C-RNAi (BL #57404), (14) UAS-
pfk2-RNAi (BL #35380), (15) UAS-pfk-RNAi (BL #34336), (16) UAS-Ldh-RNAi (BL #33640), (17) UAS-
pgi-RNAi (BL #51804), (18) UAS-pgk-RNAi (BL #33632) and (19) UAS-pyk-RNAi (BL #35218). To per-
turb signaling pathway activities, the following strains were used: (20) UAS-yki-S168A-GFP (BL
#28836), (21) UAS-Arm-S10 (Mirkovic et al., 2011), (22) UAS-Ci-5M, (23) UAS-N-act. Other strains
used include (24) myc-lacZ/FM7c (BL #12247) and (25) UAS-dMyc (BL #9674). (26) UAS-FLII12Pglu-
700md6 (Glucose sensor) is a generous gift from Dr. Stefanie Schirmeier (Volkenhoff et al., 2018).
(27) Ldh-GFP is a generous gift from Dr. Ingrid Lohmann. Strains with BL stock number were
obtained from Bloomington Drosophila Stock Center (Bloomington, IN, USA).
Flip-out clones
A 10–15 min heat shock (37˚C) was applied to larvae grown for two to three days after egg laying
(25˚C). After heat shock, the larvae were grown at 29˚C and dissected when they reached third instar
larval stage.
Immunofluorescence microscopy
Larval imaginal discs were dissected in PBS and fixed in 4% paraformaldehyde (PFA) for 15 min at
room temperature. Samples were washed with PBS with 0.1% Triton X-100 (PBST). After blocking
with 5% BSA in PBST for 1 hr at room temperature, samples were incubated with primary antibodies
overnight at 4˚C. The following primary antibodies were used: (1) mouse anti-b-Galactosidase (1:50,
DSHB 40-1a), (2) rabbit anti-dMyc (d1-717) (1:500, Santa Cruz Biotechnology, Inc sc-28207), (3) rab-
bit anti-Hipk (1:200; Blaquiere et al., 2018), (4) mouse anti-Armadillo (1:50, diluted form, DSHB N2
7A1), (5) rabbit anti-Cyclin E (d-300) (1:100, Santa Cruz Biotechnology, Inc sc-33748). After washing
with PBST, samples were incubated with Cy3- and/or Alexa Fluor 647-conjugated secondary anti-
bodies (1:500, Jackson ImmunoResearch Laboratories, Inc), DAPI (4’,6-Diamidino-2-Phenylindole,
Dihydrochloride) (final concentration: 0.2 mg per mL, Invitrogen D1306) and/or Rhodamine phalloidin
(1:500, Molecular Probes R415) for 2 hr at room temperature. Samples were mounted in 70% Glyc-
erol/PBS after wash. Images were taken on a Nikon Air laser-scanning confocal microscope and
processed by Image J.
Quantitative RT-PCR (qRT-PCR)
Imaginal discs from third instar larva were dissected in PBS and temporarily stored in RNAlater Stabi-
lization solution (Invitrogen AM7020). Total RNA was extracted using RNeasy Mini Kits (Qiagen
74101). First strand cDNA was synthesized using OneScript Plus cDNA Synthesis Kit (Abm G236).
qRT-PCR were performed using SensiFast SYBR Hi-ROS Kit (Bioline 92005) on StepOne Real-time
PCR System (Applied Biosystems).
2-NBDG uptake
Imaginal discs from third instar larva were dissected in PBS, followed by incubation with 2-NBDG
(Invitrogen N13195) at 0.3 mM for 15 min in the dark at room temperature. After rinsing with PBS,
samples were fixed and processed according to standard immunofluorescence staining protocol.
Intracellular glucose FRET analysis
The glucose sensor UAS-FLII12Pglu-700md6 was generated by Dr. Schirmeier’s group
(Volkenhoff et al., 2018). Imaginal discs expressing the sensor with or without overexpression of
hipk were mounted and imaged on the same day. The same confocal settings as previously
described (Volkenhoff et al., 2018) were used to record the CFP and FRET images. FRET efficiency
(FRET/CFP) was calculated as quotient of FRET and CFP using Image J. Since we were not determin-
ing the actual values of intracellular glucose concentrations, we did not take into account a correc-
tion for spectral bleed through and thus uncorrected FRET/CFP ratios were used to compare
glucose levels in discs of different genotypes. The values of FRET efficiency were displayed using the
Fire Lookup Table (LUT) in figures and shown in boxplots.
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Pyruvate measurement
Whole-body larvae were homogenized in PBS, followed by centrifugation at 14,000 g for 10 min.
The supernatants were used for the pyruvate assay. The pyruvate assay was performed using Enzy-
Chrom Pyruvate Assay Kit (BioAssay Systems EPYR-100) according to the manufacturer’s instruc-
tions. Absorbance at 570 nm was measured in a SpectraMax M5 fluorescent microplate reader
(Molecular Devices). Relative pyruvate levels were determined after normalizing with the protein lev-
els. Protein quantification was performed using the Bio-Rad protein assay (Bio-Rad 500–0006) and
absorbance at 595 nm was measured. Experiments were conducted with two biological replicates.
Each assay was performed with two technical replicates.
Statistics
For data analyses, unpaired two-tailed Student t-tests were used to determine p-values using Micro-
soft Excel. Bar graphs were generated by Microsoft Excel. Boxplots were generated using BoxPlotR
with data points included (Spitzer et al., 2014). We used the Spear definition to show the maximum
and minimum values by the upper and lower whiskers, respectively. The third quartile, median and
the first quartile are shown in the box accordingly to a standard boxplot.
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